QQQ   431.63 (+0.13%)
AAPL   173.19 (+0.29%)
MSFT   414.60 (+0.23%)
META   501.59 (+0.27%)
GOOGL   155.02 (+0.10%)
AMZN   183.40 (-0.12%)
TSLA   154.50 (-4.32%)
NVDA   869.08 (+1.05%)
AMD   163.17 (+1.78%)
NIO   3.76 (-3.34%)
BABA   69.54 (-1.53%)
T   16.08 (-0.99%)
F   12.06 (-1.39%)
MU   119.20 (-1.79%)
GE   154.87 (+0.76%)
CGC   6.69 (-4.15%)
DIS   113.21 (+0.23%)
AMC   2.48 (+0.40%)
PFE   25.92 (+0.04%)
PYPL   63.40 (-0.17%)
XOM   119.29 (-0.33%)
QQQ   431.63 (+0.13%)
AAPL   173.19 (+0.29%)
MSFT   414.60 (+0.23%)
META   501.59 (+0.27%)
GOOGL   155.02 (+0.10%)
AMZN   183.40 (-0.12%)
TSLA   154.50 (-4.32%)
NVDA   869.08 (+1.05%)
AMD   163.17 (+1.78%)
NIO   3.76 (-3.34%)
BABA   69.54 (-1.53%)
T   16.08 (-0.99%)
F   12.06 (-1.39%)
MU   119.20 (-1.79%)
GE   154.87 (+0.76%)
CGC   6.69 (-4.15%)
DIS   113.21 (+0.23%)
AMC   2.48 (+0.40%)
PFE   25.92 (+0.04%)
PYPL   63.40 (-0.17%)
XOM   119.29 (-0.33%)
QQQ   431.63 (+0.13%)
AAPL   173.19 (+0.29%)
MSFT   414.60 (+0.23%)
META   501.59 (+0.27%)
GOOGL   155.02 (+0.10%)
AMZN   183.40 (-0.12%)
TSLA   154.50 (-4.32%)
NVDA   869.08 (+1.05%)
AMD   163.17 (+1.78%)
NIO   3.76 (-3.34%)
BABA   69.54 (-1.53%)
T   16.08 (-0.99%)
F   12.06 (-1.39%)
MU   119.20 (-1.79%)
GE   154.87 (+0.76%)
CGC   6.69 (-4.15%)
DIS   113.21 (+0.23%)
AMC   2.48 (+0.40%)
PFE   25.92 (+0.04%)
PYPL   63.40 (-0.17%)
XOM   119.29 (-0.33%)
QQQ   431.63 (+0.13%)
AAPL   173.19 (+0.29%)
MSFT   414.60 (+0.23%)
META   501.59 (+0.27%)
GOOGL   155.02 (+0.10%)
AMZN   183.40 (-0.12%)
TSLA   154.50 (-4.32%)
NVDA   869.08 (+1.05%)
AMD   163.17 (+1.78%)
NIO   3.76 (-3.34%)
BABA   69.54 (-1.53%)
T   16.08 (-0.99%)
F   12.06 (-1.39%)
MU   119.20 (-1.79%)
GE   154.87 (+0.76%)
CGC   6.69 (-4.15%)
DIS   113.21 (+0.23%)
AMC   2.48 (+0.40%)
PFE   25.92 (+0.04%)
PYPL   63.40 (-0.17%)
XOM   119.29 (-0.33%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Samsara Inc. stock logo
IOT
Samsara
$30.07
-1.2%
$34.95
$16.63
$40.54
$16.55B1.563.64 million shs384,269 shs
Newfield Exploration stock logo
NFX
Newfield Exploration
$17.07
$0.00
$12.45
$31.46
$3.43B1.858.80 million shsN/A
Revive Therapeutics Ltd stock logo
RVV
Revive Therapeutics
C$0.08
+14.3%
C$0.08
C$0.07
C$0.25
C$5.79MN/A93,085 shs212,852 shs
TRPXY
Therapix Biosciences
$6.03
+0.5%
$6.03
$2.75
$22.40
$6.25MN/A12,316 shs53,500 shs
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Samsara Inc. stock logo
IOT
Samsara
-4.55%-9.84%-14.90%-9.54%+52.76%
Newfield Exploration stock logo
NFX
Newfield Exploration
0.00%0.00%0.00%0.00%0.00%
Revive Therapeutics Ltd stock logo
RVV
Revive Therapeutics
0.00%0.00%0.00%0.00%0.00%
TRPXY
Therapix Biosciences
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Samsara Inc. stock logo
IOT
Samsara
0.6711 of 5 stars
1.22.00.00.02.04.20.6
Newfield Exploration stock logo
NFX
Newfield Exploration
N/AN/AN/AN/AN/AN/AN/AN/A
Revive Therapeutics Ltd stock logo
RVV
Revive Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
TRPXY
Therapix Biosciences
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Samsara Inc. stock logo
IOT
Samsara
2.44
Hold$31.564.94% Upside
Newfield Exploration stock logo
NFX
Newfield Exploration
N/AN/AN/AN/A
Revive Therapeutics Ltd stock logo
RVV
Revive Therapeutics
N/AN/AN/AN/A
TRPXY
Therapix Biosciences
N/AN/AN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Samsara Inc. stock logo
IOT
Samsara
$937.39M17.66N/AN/A$1.68 per share17.90
Newfield Exploration stock logo
NFX
Newfield Exploration
$1.77B1.94$4.50 per share3.79$7.05 per share2.42
Revive Therapeutics Ltd stock logo
RVV
Revive Therapeutics
N/AN/AC$0.03 per share3.18C$0.02 per shareN/A
TRPXY
Therapix Biosciences
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Samsara Inc. stock logo
IOT
Samsara
-$286.73M-$0.53N/AN/AN/A-30.59%-22.90%-12.81%6/6/2024 (Estimated)
Newfield Exploration stock logo
NFX
Newfield Exploration
$427M$2.157.945.170.3721.14%43.65%13.21%N/A
Revive Therapeutics Ltd stock logo
RVV
Revive Therapeutics
N/A-C$0.02N/AN/AN/AN/AN/A6/4/2024 (Estimated)
TRPXY
Therapix Biosciences
N/AN/A0.00N/AN/AN/AN/AN/A

Latest ROQ, IOT, RVV, NFX, and TRPXY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/7/2024Q4 2024
Samsara Inc. stock logo
IOT
Samsara
-$0.08-$0.08N/A$0.05$258.56 million$276.27 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Samsara Inc. stock logo
IOT
Samsara
N/AN/AN/AN/AN/A
Newfield Exploration stock logo
NFX
Newfield Exploration
N/AN/AN/AN/AN/A
Revive Therapeutics Ltd stock logo
RVV
Revive Therapeutics
N/AN/AN/AN/AN/A
TRPXY
Therapix Biosciences
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Samsara Inc. stock logo
IOT
Samsara
N/A
1.50
1.46
Newfield Exploration stock logo
NFX
Newfield Exploration
1.30
0.72
0.70
Revive Therapeutics Ltd stock logo
RVV
Revive Therapeutics
N/A
6.14
6.03
TRPXY
Therapix Biosciences
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Samsara Inc. stock logo
IOT
Samsara
89.39%
Newfield Exploration stock logo
NFX
Newfield Exploration
97.87%
Revive Therapeutics Ltd stock logo
RVV
Revive Therapeutics
N/A
TRPXY
Therapix Biosciences
N/A

Insider Ownership

CompanyInsider Ownership
Samsara Inc. stock logo
IOT
Samsara
66.14%
Newfield Exploration stock logo
NFX
Newfield Exploration
0.59%
Revive Therapeutics Ltd stock logo
RVV
Revive Therapeutics
N/A
TRPXY
Therapix Biosciences
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Samsara Inc. stock logo
IOT
Samsara
2,895550.52 million186.41 millionNot Optionable
Newfield Exploration stock logo
NFX
Newfield Exploration
N/A200.93 millionN/AOptionable
Revive Therapeutics Ltd stock logo
RVV
Revive Therapeutics
N/A72.41 millionN/ANot Optionable
TRPXY
Therapix Biosciences
81.04 millionN/ANot Optionable

ROQ, IOT, RVV, NFX, and TRPXY Headlines

No headlines for this company have been tracked by MarketBeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Samsara logo

Samsara

NYSE:IOT
Samsara Inc. provides solutions that connects physical operations data to its connected operations cloud in the United States and internationally. The company's Connected Operations Cloud includes Data Platform, which ingests, aggregates, and enriches data from its IoT devices and has embedded capabilities for AI, workflows and analytics, alerts, API connections, and data security and privacy. Its applications include video-based safety that enables customers to build a safety program and protect their teams with AI-enabled video; vehicle telematics which provides visibility into real-time vehicle location and diagnostics with GPS tracking, routing and dispatch, fuel efficiency management, electric vehicle usage and charge planning, preventative maintenance, and insights to manage fuel and energy costs; and mobile apps and workflows that improves productivity for frontline workers and enables regulatory compliance for workers to see upcoming jobs, capture electronic documents, perform maintenance inspections, maintain compliance logs, and message with back-office administration. The company also provides equipment monitoring which offers visibility and management of unpowered and powered assets, ranging from generators and compressors to heavy construction equipment and trailers to improve operating efficiency, prevent unplanned downtime, and avoid critical safety and compliance issues; and site visibility that provides remote visibility into sites to improve onsite security, safety, and incident response times. It serves transportation, wholesale and retail trade, construction, field services, logistics, utilities and energy, healthcare and education, manufacturing, food and beverage, and other industries, as well as government. Samsara Inc. was incorporated in 2015 and is headquartered in San Francisco, California.
Newfield Exploration logo

Newfield Exploration

NYSE:NFX
Newfield Exploration Company, an independent energy company, engages in the exploration, development, and production of crude oil, natural gas, and natural gas liquids in the United States. The company has operations principally in the Anadarko and Arkoma basins of Oklahoma, the Williston Basin of North Dakota, and the Uinta Basin of Utah. It also holds oil producing assets offshore China. The company was founded in 1988 and is headquartered in The Woodlands, Texas.
Revive Therapeutics logo

Revive Therapeutics

CVE:RVV
Revive Therapeutics Ltd. develops and commercializes cannabinoid-based products in Canada. The company develops REV-002, a bucillamine that has completed Phase II-A clinical studies for the treatment of acute gout flares. Its product pipeline also includes REV-004, a bucillamine for the treatment of cystinurial. The company has a research and development supply and collaboration agreement with WeedMD Inc. Revive Therapeutics Ltd. was incorporated in 2012 and is headquartered in Vaughan, Canada.

Therapix Biosciences

OTCMKTS:TRPXY
Therapix Biosciences Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. Its drug development programs include THX-110, which has completed Phase II a clinical trial for the treatment of Tourette syndrome and Obstructive Sleep Apnea; THX-160, which has completed two preliminary preclinical studies for the treatment of acute and chronic pain; and THX-210 for the treatment of autism spectrum disorder and epilepsy. Therapix Biosciences Ltd. has a collaboration with The University of Calgary to evaluate the analgesic effect of Therapix's CB2R agonist proprietary drug candidate, THX-160. The company was formerly known as NasVax Ltd. and changed its name to Therapix Biosciences Ltd. in November 2013. Therapix Biosciences Ltd. was founded in 2004 and is headquartered in Givatayim, Israel.